Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
Mismatch repair detection (MRD) was used to screen 93 matched tumor-normal sample pairs and 22 cell lines for somatic mutations in 30 cancer relevant genes. Using a starting amount of only 150 ng of genomic DNA, we screened 102 kb of sequence for somatic mutations in colon and breast cancer. A total of 152 somatic mutations were discovered, encompassing previously reported mutations, such as BRAF V600E and KRAS G12S, G12V, and G13D, as well as novel mutations, including some in genes in which somatic mutations have not previously been reported, such as MAP2K1 and MAP2K2. The distribution of mutations ranged widely within and across tumor types. The functional significance of many of these mutations is not understood, with patterns of selection only evident in KRAS and BRAF in colon cancer. These results present a novel approach to high-throughput mutation screening using small amounts of starting material and reveal a mutation spectrum across 30 genes in a large cohort of breast and colorectal cancers.
Bentivegna
Steven
S
Molecular Profiling-Pharmacogenomics, Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut, USA.
Zheng
Jianbiao
J
Namsaraev
Eugeni
E
Carlton
Victoria E H
VE
Pavlicek
Adam
A
Moorhead
Martin
M
Siddiqui
Farooq
F
Wang
Zhiyong
Z
Lee
Liana
L
Ireland
James S
JS
Suyenaga
Kent
K
Willis
Thomas D
TD
Faham
Malek
M
Seymour
Albert B
AB
D001483:Base Sequence; D001943:Breast Neoplasms / Q000235:genetics*; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000235:genetics*; D053843:DNA Mismatch Repair; D004252:DNA Mutational Analysis / Q000379:methods*; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation
D004273:DNA, Neoplasm